Mayo Clinic doctors and scientists are studying ways to improve the diagnosis and treatment of Waldenstrom macroglobulinemia. Learn more about hematology research.
Cancer research is conducted in coordination with the Mayo Clinic Cancer Center. The Mayo Clinic Cancer Center receives funding from the National Cancer Institute and is designated as a comprehensive cancer center — recognition for an institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.
See a list of publications by Mayo Clinic authors on Waldenstrom macroglobulinemia on PubMed, a service of the National Library of Medicine.
Aug. 21, 2015
- Stephen M. Ansell, M.D., Ph.D.
- Leif Bergsagel, M.D.
- Asher A. Chanan-Khan, M.D.
- Rafael Fonseca, M.D.
- Morie A. Gertz, M.D.
- Prashant Kapoor, M.D.
- Robert A. Kyle, M.D.
- Michelle L. Mauermann, M.D.
- Joseph R. Mikhael, M.D.
- Craig B. Reeder, M.D.
- Keith Stewart, M.B., Ch.B.
- Kasi MP, et al. Waldenstrom macroglobulinemia. Clinical Advances in Hematology & Oncology. 2015;13:56.
- AskMayoExpert. Waldenstrom macroglobulinemia. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
- Gertz M. Waldenstrom macroglobulinemia: 2015 update on diagnosis, risk stratification and management. American Journal of Hematology. 2015;90:347.
- Cook AJ. Decision Support System. Mayo Clinic, Rochester, Minn. March 17, 2015.